246 related articles for article (PubMed ID: 17477782)
1. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
4. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
[TBL] [Abstract][Full Text] [Related]
5. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
[TBL] [Abstract][Full Text] [Related]
9. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
11. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
12. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
13. Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.
Cui X; Lu X; Hiura M; Omori H; Miyazaki W; Katoh T
Environ Health Prev Med; 2013 Mar; 18(2):136-42. PubMed ID: 22961351
[TBL] [Abstract][Full Text] [Related]
14. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.
Hou SM; Ryberg D; Fält S; Deverill A; Tefre T; Børresen AL; Haugen A; Lambert B
Carcinogenesis; 2000 Jan; 21(1):49-54. PubMed ID: 10607733
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore.
Seow A; Zhao B; Lee EJ; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee HP
Carcinogenesis; 2001 Apr; 22(4):673-7. PubMed ID: 11285205
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
[TBL] [Abstract][Full Text] [Related]
17. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
19. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
20. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
